Novel Flavonoid Senotherapeutics Identified by Phenotypic Drug Discovery Reduce Senescence and Improve Multiple Markers of Healthspan.
Zhang LJ, Salekeen R, Soto-Palma C, Wu Q, He Y, Elsallabi O, Bdiri B, Hughes B, Nunes A, Xu W, Zhang B, Mohamed A, McGowan SJ, Angelini L, O'Kelly R, Kamenecka TM, Niedernhofer LJ, Robbins PD.
Senescent cells are a key driver of aging and contribute to many age-related diseases. Senolytics, agents that selectively eliminate senescent cells, offer a promising therapeutic strategy to treat age-related diseases but face significant barriers to clinical...